Sale!

GATAD2B Gene Mental Retardation Autosomal Dominant Type 18 Genetic Test

4,400 د.إ

-21%

The GATAD2B Gene Mental Retardation Autosomal Dominant Type 18 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the GATAD2B gene. This gene is associated with Autosomal Dominant Mental Retardation Type 18, a condition that affects cognitive development and may cause other neurological issues. The test plays a crucial role in understanding the genetic basis of the disorder, facilitating early intervention and personalized management strategies for affected individuals. Priced at 4400 AED, this test is a valuable resource for families seeking answers to developmental delays and intellectual challenges within their loved ones, offering them a pathway towards tailored care and support.

Home  Sample collection service available

  • 100% accuaret DNA Results
  • Ranked as Most trusted Genetic DNA Lab
Guaranteed Safe Checkout

GATAD2B Gene Mental Retardation Autosomal Dominant Type 18 Genetic Test

Welcome to DNA Labs UAE, your trusted genetic testing laboratory in the UAE. Today, we will be discussing the GATAD2B Gene Mental Retardation Autosomal Dominant Type 18 Genetic Test.

Test Name: GATAD2B Gene Mental Retardation Autosomal Dominant Type 18 Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information:

Before undergoing the GATAD2B Gene Mental Retardation Autosomal Dominant Type 18 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by GATAD2B Gene Mental Retardation Autosomal Dominant Type 18.

Test Details:

The GATAD2B gene is associated with a condition called Mental Retardation Autosomal Dominant Type 18 (MRD18). Our genetic test, Next-Generation Sequencing (NGS), is used to identify mutations or variations in the GATAD2B gene that may be responsible for MRD18.

NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or the entire genome. It can detect small genetic changes, such as single nucleotide variants (SNVs), insertions, deletions, and larger structural variations.

To perform the genetic test, we will need a DNA sample. This can be obtained through a blood sample or saliva from the individual being tested. The DNA sample will then be sequenced using NGS technology to identify any variations or mutations in the GATAD2B gene.

The results of the NGS genetic test can help confirm a diagnosis of MRD18 in individuals suspected of having the condition. It can also provide information about the specific genetic variant present, which may be helpful for genetic counseling and family planning.

It is important to note that this genetic test should be ordered and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate counseling and guidance based on the test results.

At DNA Labs UAE, we are committed to providing accurate and reliable genetic testing services. If you have any questions or would like to schedule an appointment for the GATAD2B Gene Mental Retardation Autosomal Dominant Type 18 Genetic Test, please contact us.

Test Name GATAD2B Gene Mental retardation autosomal dominant type 18 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GATAD2B Gene Mental retardation, autosomal dominant type 18 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GATAD2B Gene Mental retardation, autosomal dominant type 18
Test Details

The GATAD2B gene is associated with a condition called mental retardation, autosomal dominant type 18 (MRD18). This genetic test, known as Next-Generation Sequencing (NGS), is used to identify mutations or variations in the GATAD2B gene that may be responsible for MRD18.

NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or the entire genome. It can detect small genetic changes, such as single nucleotide variants (SNVs), insertions, deletions, and larger structural variations.

The genetic test involves obtaining a DNA sample, usually through a blood sample or saliva, from the individual being tested. The DNA is then sequenced using NGS technology to identify any variations or mutations in the GATAD2B gene.

The results of the NGS genetic test can help confirm a diagnosis of MRD18 in individuals suspected of having the condition. It can also provide information about the specific genetic variant present, which may be helpful for genetic counseling and family planning.

It is important to note that this genetic test should be ordered and interpreted by a qualified healthcare professional, such as a geneticist or genetic counselor, who can provide appropriate counseling and guidance based on the test results.